Stocks-FOLD-Amicus Therapeutics Inc

FOLD Amicus Therapeutics Inc

11.27 -0.24 (-2.06%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Stocks-FOLD-Amicus Therapeutics Inc
FOLD Amicus Therapeutics Inc
Trade

Overview

Prev Close 11.51
Day's Range 11.24 - 11.48
52 Week Range 9.01 - 14.54
Average Volume (3M) 2.63M
1-Year Return -15.06%
Beta1.137
Market Cap 3.41B
P/E Ratio-28.8
Revenue455.66M
EPS-0.3997
Dividend (Yield) 0 (0%)
Sector
Health Technology
Industry
Pharmaceuticals Major
CEO
Bradley Lewis Campbell, MBA
Employees
517

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Amicus Therapeutics Inc's revenues increased by 21.30% and amounted to 399.36M. Net income increased by 35.92% to -151.58M. Net assets increased by 30.17% to 160.17M and EPS increased from -0.82 to -0.51.
FOLD's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income09/2312/2303/2406/24-100M-50M050M100M150M
Gross Margin
87.96%
Net Profit Margin
-98.69%
Operating Margin
-5.58%
Return On Investment
-38.37%
09/23
12/23
03/24
06/24
Total Revenue
103.5M
115.08M
110.4M
126.67M
Gross Profit
91.33M
N/A
94.68M
113.23M
Operating Income
-15.03M
N/A
-21.68M
14.97M
Net Income
-21.58M
-33.84M
-48.42M
-15.7M